AstraZeneca, Amgen's Tezspire Pre-filled Pen Receives FDA Approval In US For Asthma

AstraZeneca Plc (AZN) and Amgen Inc (AMGN)'s Tezspire got FDA approval in the US, based on the pathfinder clinical trial program.

The approval is for self-administration in a pre-filled, single-use pen for patients aged 12 years and older with severe asthma. Tezspire is currently approved for the treatment of severe asthma in the US, EU, Japan, and other countries.4-6

AstraZeneca said 92 percent of healthcare providers, patients and caregivers were able to successfully administer Tezspire in the clinic and at home throughout the PATH-HOME trial.

Earlier Tezspire self-administration and the pre-filled pen got approval in the European Union.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ford Motor Co. has once again raised the price of its popular F-150 Lightning electric pickup truck after the automaker resumed its production that was halted following electric vehicle battery fire incident. The company will also resume shipments of the Lightning this week, reports said. Paducah, Kentucky-based Higdon Outdoors LLC is recalling certain battery packs and replacement batteries citing fire and/or burn hazards, the U.S. Consumer Product Safety Commission said. The recall includes lithium-ion battery packs and replacement batteries on XS Series Pulsators, Swimmers, Crazy Kicker, and Flasher motion decoys used for waterfowl hunting. New York-based Delta Enterprise Corp. is recalling about 43,380 units of 2-in-1 outdoor kids swings citing fall hazard, the U.S. Consumer Product Safety Commission said. This recall involves 2-in-1 Outdoor Kids Swing with model numbers SW86508MM, SW86516MN, SW86575MM, SW86576MN and SW86577PW.
Follow RTT